CLINICAL_TRIALS
trial_result
· 2019-06-06
Clinical Trial Update: Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Summary
Phase 2 rollover study update for BIBF 1120 in idiopathic pulmonary fibrosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2019-06-06